KOMPLEKS OKSOVANADIUM(IV) - ASETILASETON DAN OKSOVANADIUM(IV) - SALEN SEBAGAI OKSIDATOR SISTEIN O X OVANADIUM(IV) - A CETYLACETONE AND O X OVANADIUM(IV) - SALEN COMPLEX AS A CYSTEINE OXIDIZER
The complex of oxovanadium (IV) has been widely studied as a type 2 antidiabetic. One of <br /> <br /> the mechanisms of the oxovanadium (IV) complex as an antidiabetic is through inhibition of <br /> <br /> protein tyrosine phosphatase (PTP) activity present <br /...
Saved in:
Main Author: | |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/27992 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
id |
id-itb.:27992 |
---|---|
spelling |
id-itb.:279922018-06-22T10:01:07ZKOMPLEKS OKSOVANADIUM(IV) - ASETILASETON DAN OKSOVANADIUM(IV) - SALEN SEBAGAI OKSIDATOR SISTEIN O X OVANADIUM(IV) - A CETYLACETONE AND O X OVANADIUM(IV) - SALEN COMPLEX AS A CYSTEINE OXIDIZER MADE DWI ADNYANA NIM: 10514064, I Indonesia Final Project INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/27992 The complex of oxovanadium (IV) has been widely studied as a type 2 antidiabetic. One of <br /> <br /> the mechanisms of the oxovanadium (IV) complex as an antidiabetic is through inhibition of <br /> <br /> protein tyrosine phosphatase (PTP) activity present <br /> <br /> in receptor insulin. The ability of the <br /> <br /> oxovanadium (IV) complex to inhibit PTP is suspected by forming a coordination bond <br /> <br /> between cysteine <br /> <br /> and the oxovanadium (IV) complex or oxidizing cysteine <br /> <br /> to cystine or <br /> <br /> sulfonic acid derivatives. Cysteine <br /> <br /> is o <br /> <br /> ne of the amino acids contained in the active side of <br /> <br /> PTP. In this study we studied the ability of the oxovanadium (IV) <br /> <br /> - <br /> <br /> acetylacetone, [VO(acac) <br /> <br /> 2 <br /> <br /> ] <br /> <br /> and oxovanadium(IV) <br /> <br /> - <br /> <br /> salen, [VO(salen)] complexes to oxidize cysteine <br /> <br /> to cystine. This is one <br /> <br /> model of in vi <br /> <br /> tro study to study the potential of a complex as a type 2 antidibetic. Two complex <br /> <br /> compounds that have been synthesized in this study are complex [VO(acac) <br /> <br /> 2 <br /> <br /> ] and complex <br /> <br /> [VO(salen)]. The two complex compounds have been characterized by IR, UV <br /> <br /> - <br /> <br /> Vis, MSB and <br /> <br /> elemental analysis. Both complex compounds are paramagnetic. The ability of both complexes <br /> <br /> as cysteine <br /> <br /> oxidators has been studied in buffer buffer pH 7.4 at 37 ° C. <br /> <br /> The results of FT <br /> <br /> - <br /> <br /> IR <br /> <br /> characterization of cysteine oxidation products by the complex [VO(a <br /> <br /> cac) <br /> <br /> 2 <br /> <br /> ] and [VO(salen)] <br /> <br /> showed the same absorption at wave number 540 <br /> <br /> , <br /> <br /> 11 cm <br /> <br /> - <br /> <br /> 1. This wavelength indicates the <br /> <br /> vibration of S <br /> <br /> - <br /> <br /> S so it is suspected that the product formed is a cystine compound text |
institution |
Institut Teknologi Bandung |
building |
Institut Teknologi Bandung Library |
continent |
Asia |
country |
Indonesia Indonesia |
content_provider |
Institut Teknologi Bandung |
collection |
Digital ITB |
language |
Indonesia |
description |
The complex of oxovanadium (IV) has been widely studied as a type 2 antidiabetic. One of <br />
<br />
the mechanisms of the oxovanadium (IV) complex as an antidiabetic is through inhibition of <br />
<br />
protein tyrosine phosphatase (PTP) activity present <br />
<br />
in receptor insulin. The ability of the <br />
<br />
oxovanadium (IV) complex to inhibit PTP is suspected by forming a coordination bond <br />
<br />
between cysteine <br />
<br />
and the oxovanadium (IV) complex or oxidizing cysteine <br />
<br />
to cystine or <br />
<br />
sulfonic acid derivatives. Cysteine <br />
<br />
is o <br />
<br />
ne of the amino acids contained in the active side of <br />
<br />
PTP. In this study we studied the ability of the oxovanadium (IV) <br />
<br />
- <br />
<br />
acetylacetone, [VO(acac) <br />
<br />
2 <br />
<br />
] <br />
<br />
and oxovanadium(IV) <br />
<br />
- <br />
<br />
salen, [VO(salen)] complexes to oxidize cysteine <br />
<br />
to cystine. This is one <br />
<br />
model of in vi <br />
<br />
tro study to study the potential of a complex as a type 2 antidibetic. Two complex <br />
<br />
compounds that have been synthesized in this study are complex [VO(acac) <br />
<br />
2 <br />
<br />
] and complex <br />
<br />
[VO(salen)]. The two complex compounds have been characterized by IR, UV <br />
<br />
- <br />
<br />
Vis, MSB and <br />
<br />
elemental analysis. Both complex compounds are paramagnetic. The ability of both complexes <br />
<br />
as cysteine <br />
<br />
oxidators has been studied in buffer buffer pH 7.4 at 37 ° C. <br />
<br />
The results of FT <br />
<br />
- <br />
<br />
IR <br />
<br />
characterization of cysteine oxidation products by the complex [VO(a <br />
<br />
cac) <br />
<br />
2 <br />
<br />
] and [VO(salen)] <br />
<br />
showed the same absorption at wave number 540 <br />
<br />
, <br />
<br />
11 cm <br />
<br />
- <br />
<br />
1. This wavelength indicates the <br />
<br />
vibration of S <br />
<br />
- <br />
<br />
S so it is suspected that the product formed is a cystine compound |
format |
Final Project |
author |
MADE DWI ADNYANA NIM: 10514064, I |
spellingShingle |
MADE DWI ADNYANA NIM: 10514064, I KOMPLEKS OKSOVANADIUM(IV) - ASETILASETON DAN OKSOVANADIUM(IV) - SALEN SEBAGAI OKSIDATOR SISTEIN O X OVANADIUM(IV) - A CETYLACETONE AND O X OVANADIUM(IV) - SALEN COMPLEX AS A CYSTEINE OXIDIZER |
author_facet |
MADE DWI ADNYANA NIM: 10514064, I |
author_sort |
MADE DWI ADNYANA NIM: 10514064, I |
title |
KOMPLEKS OKSOVANADIUM(IV) - ASETILASETON DAN OKSOVANADIUM(IV) - SALEN SEBAGAI OKSIDATOR SISTEIN O X OVANADIUM(IV) - A CETYLACETONE AND O X OVANADIUM(IV) - SALEN COMPLEX AS A CYSTEINE OXIDIZER |
title_short |
KOMPLEKS OKSOVANADIUM(IV) - ASETILASETON DAN OKSOVANADIUM(IV) - SALEN SEBAGAI OKSIDATOR SISTEIN O X OVANADIUM(IV) - A CETYLACETONE AND O X OVANADIUM(IV) - SALEN COMPLEX AS A CYSTEINE OXIDIZER |
title_full |
KOMPLEKS OKSOVANADIUM(IV) - ASETILASETON DAN OKSOVANADIUM(IV) - SALEN SEBAGAI OKSIDATOR SISTEIN O X OVANADIUM(IV) - A CETYLACETONE AND O X OVANADIUM(IV) - SALEN COMPLEX AS A CYSTEINE OXIDIZER |
title_fullStr |
KOMPLEKS OKSOVANADIUM(IV) - ASETILASETON DAN OKSOVANADIUM(IV) - SALEN SEBAGAI OKSIDATOR SISTEIN O X OVANADIUM(IV) - A CETYLACETONE AND O X OVANADIUM(IV) - SALEN COMPLEX AS A CYSTEINE OXIDIZER |
title_full_unstemmed |
KOMPLEKS OKSOVANADIUM(IV) - ASETILASETON DAN OKSOVANADIUM(IV) - SALEN SEBAGAI OKSIDATOR SISTEIN O X OVANADIUM(IV) - A CETYLACETONE AND O X OVANADIUM(IV) - SALEN COMPLEX AS A CYSTEINE OXIDIZER |
title_sort |
kompleks oksovanadium(iv) - asetilaseton dan oksovanadium(iv) - salen sebagai oksidator sistein o x ovanadium(iv) - a cetylacetone and o x ovanadium(iv) - salen complex as a cysteine oxidizer |
url |
https://digilib.itb.ac.id/gdl/view/27992 |
_version_ |
1822922431601311744 |